Peter Goodhand is a senior executive and board member in the health research advancement community. Starting in the UK in 1980 and moving to North America in 1986, Goodhand had a 20-year career in the global medical technology industry, including international leadership roles with American Cyanamid and Johnson & Johnson. In 2003 he became the Founding Managing Director of the Health Technology Exchange (HTX) and the Chairman of the Board in 2004. He then spent 8 years at the Canadian Cancer Society, as a President and CEO before presiding the Ontario Institute for Cancer Research for 2 additional years. He is now the CEO of The Global Alliance for Genomics and Health.
GapSummit is the premier, global, intergenerational biotechnology summit that attracts world leaders and the next generation of leaders to substantively discuss pressing challenges facing the bioeconomy and catalyze innovation to address these challenges.
GBR is a not-for-profit that connects biotech think-tanks, industrial leaders and research pioneers to young bio-leaders of tomorrow. GBR is solely led by young passionate and engaged researchers, students and professionals from across the world. GapSummit is GBR’s flagship event to advance its mission of developing and inspiring the next generation of leaders in the global bio-economy.